HKSE:02526 (China)
Â
Class H
HK$
355.4
-18.6 (-4.97%)
Aug 14
Business Description
Hangzhou Diagens Biotechnology Co Ltd
ISIN : CNE100007JC7
Share Class Description:
HKSE:02526: Class HCompare
Compare
Traded in other countries / regions
02526.Hong Kong IPO Date
2026-03-30Description
Hangzhou Diagens Biotechnology Co Ltd and its subsidiaries are involved in the development and commercialisation of medical imaging artificial intelligence technologies and medical imaging equipment. It has self-developed a diversified portfolio, including six medical imaging software products, three commercialized medical devices, four key reagents and consumables and two technology licensing offerings. Its Core Product, AI AutoVision, is an auxiliary diagnostic software designed to undertake intelligent analysis on chromosome karyotyping. The majority of the company's revenue is derived from Technology Licensing, mainly in the Chinese mainland.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 11.76 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.93 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 405.02 | |||||
Beneish M-Score | -3.25 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.19 | |||||
9-Day RSI | 54.15 | |||||
14-Day RSI | 54.48 | |||||
3-1 Month Momentum % | 16.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.32 | |||||
Quick Ratio | 6.98 | |||||
Cash Ratio | 5.9 | |||||
Days Inventory | 381.33 | |||||
Days Sales Outstanding | 238.6 | |||||
Days Payable | 301.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.6 | |||||
Operating Margin % | -73.4 | |||||
Net Margin % | -87.94 | |||||
EBITDA Margin % | -84.49 | |||||
FCF Margin % | -46.95 | |||||
OCF Margin % | -46.69 | |||||
ROE % | -16.76 | |||||
ROA % | -14.13 | |||||
ROIC % | -35.43 | |||||
ROC (Joel Greenblatt) % | -83.56 | |||||
ROCE % | -16.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 384.63 | |||||
PB Ratio | 35.22 | |||||
Price-to-Tangible-Book | 35.29 | |||||
EV-to-EBIT | -425.84 | |||||
EV-to-EBITDA | -441.34 | |||||
EV-to-Revenue | 372.89 | |||||
EV-to-FCF | -794.3 | |||||
| Price-to-Net-Current-Asset-Value | 39.18 | |||||
| Price-to-Net-Cash | 50.63 | |||||
Earnings Yield (Greenblatt) % | -0.23 | |||||
FCF Yield % | -0.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou Diagens Biotechnology Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 82.176 | ||
| EPS (TTM) (HK$) | -0.813 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 54.48 | ||
| 14-Day ATR (HK$) | 36.541383 | ||
| 20-Day SMA (HK$) | 331.7 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 178 - 489 | ||
| Shares Outstanding (Mil) | 88.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hangzhou Diagens Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hangzhou Diagens Biotechnology Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hangzhou Diagens Biotechnology Co Ltd Frequently Asked Questions
What is Hangzhou Diagens Biotechnology Co Ltd(HKSE:02526)'s stock price today?
The current price of HKSE:02526 is HK$355.40. The 52 week high of HKSE:02526 is HK$489.00 and 52 week low is HK$178.00.
When is next earnings date of Hangzhou Diagens Biotechnology Co Ltd(HKSE:02526)?
The next earnings date of Hangzhou Diagens Biotechnology Co Ltd(HKSE:02526) is .
Does Hangzhou Diagens Biotechnology Co Ltd(HKSE:02526) pay dividends? If so, how much?
Hangzhou Diagens Biotechnology Co Ltd(HKSE:02526) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hangzhou Diagens Biotechnology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers